About

Publications While At HealthPartners

selected publications

Journal Article

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 

Neurooncol Adv. 2023

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies. 

British Journal of Cancer. 2023

The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma. 

Melanoma Research. 2023

Contact

full name

T. M. Tarasow

Quick Info

 

Collaboration

Co-author network

Map of science